Answers are grounded in this paper and cite their sources.
Highlights how baseline risk influences trial design and the interpretation of absolute versus relative risk reduction in HFrEF.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Spall et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: